Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Olson AL, Saliba RM, Oran B, Chen J, Alousi A, Ahmed S, Bashir Q, Ciurea SO, Hosing C, Seon Im J, Kebriaei P, Khouri IF, Mehta R, Nieto Y, Parmar S, Rezvani K, Shah N, Shpall E, Srour SA, Qazilbash M, Andersson BS, Champlin R, Popat UR.
Olson AL, et al. Among authors: bashir q.
Acta Haematol. 2021;144(1):74-81. doi: 10.1159/000507012. Epub 2020 Jun 30.
Acta Haematol. 2021.
PMID: 32604096